Supernus Pharmaceuticals, Inc.
Supernus Pharmaceuticals, Inc. (SUPN) — Form 8-K: Current report
About this filing
Supernus Pharmaceuticals, Inc. (SUPN) filed an 8-K on Nov 2, 2026 reporting a delisting or listing-rule notice or listing transfer (Item 3.01).
Key facts
- Item 3.01 · Delisting or listing-rule notice or listing transfer
More SUPN filings
- S-8 POS
Filed Nov 2, 2026
- S-8 POS
Filed Nov 2, 2026
- S-8 POS
Filed Nov 2, 2026
- 25-NSE
Filed Nov 2, 2026
- S-8 POS
Filed Nov 2, 2026
- S-8 POS
Filed Nov 2, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.